Sabina Gainotti
Biographic Data
| ID | 7918136 |
|---|---|
| NAME | Sabina Gainotti |
| GIVEN NAMES | Sabina |
| FAMILY NAME | Gainotti |
| SIGNATURE | GAINOTTI S |
| AFFILIATIONS | Istituto Superiore di Sanità |
| ORCID | 0000-0002-6006-9064 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Decentralized clinical trials (DCTs)
Decentralized clinical trials (DCTs) are studies in which the need for patients to physically access hospital-based trial sites is reduced or eliminated. The CoViD-19 pandemic has caused a significant increase in DCT: a survey shows that 76% of pharmaceutical companies, device manufacturers, and Contract Research Organizations adopted decentralized techniques during the early phase of the pandemic. The implementation of DCTs relies on the use of …
Recommendations for Improving the Quality of Rare Disease Registries
Rare diseases (RD) patient registries are powerful instruments that help develop clinical research, facilitate the planning of appropriate clinical trials, improve patient care, and support healthcare management. They constitute a key information system that supports the activities of European Reference Networks (ERNs) on rare diseases. A rapid proliferation of RD registries has occurred during the last years and there is a need to develop guidan…
No prominent works on this page.
Recommendations for Improving the Quality of Rare Disease Registries
Rare diseases (RD) patient registries are powerful instruments that help develop clinical research, facilitate the planning of appropriate clinical trials, improve patient care, and support healthcare management. They constitute a key information system that supports the activities of European Reference Networks (ERNs) on rare diseases. A rapid proliferation of RD registries has occurred during the last years and there is a need to develop guidan…
Decentralized clinical trials (DCTs)
Decentralized clinical trials (DCTs) are studies in which the need for patients to physically access hospital-based trial sites is reduced or eliminated. The CoViD-19 pandemic has caused a significant increase in DCT: a survey shows that 76% of pharmaceutical companies, device manufacturers, and Contract Research Organizations adopted decentralized techniques during the early phase of the pandemic. The implementation of DCTs relies on the use of …
Engineering (2 works) · Audit (1 work) · Biobank (1 work) · Bioinformatics (1 work) · Biomedical Text Mining and Ontologies (1 work) · Business (1 work) · Cancer Genomics and Diagnostics (1 work) · Computer Science (1 work) · Damages (1 work) · Data quality (1 work)